HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer (PC) has a poor prognosis. Even though surgical resection and adjuvant chemotherapy is the most effective therapy, recurrence remains common. In this paper, we investigate the effectiveness of dual inhibition of hepatocyte growth factor (HGF) and c-MET when used as...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Pang, Tony C. Y., Xu, Zhihong, Mekapogu, Alpha Raj, Pothula, Srinivasa, Becker, Therese, Corley, Susan, Wilkins, Marc R., Goldstein, David, Pirola, Romano, Wilson, Jeremy, Apte, Minoti
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8199621/
https://ncbi.nlm.nih.gov/pubmed/34199452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112763
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller